In the Adaptive COVID-19 Treatment Trial involving more than 1,000 patients testing the efficacy of the antiviral remdesivir, only 20% of participants are Black and 23% are Hispanic or Native American.
from WebMD Healthhttps://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/features/_2018/01_2018/diversity_of_clinical_trials_benefits_americans_features/650x350_diversity_of_clinical_trials_benefits_americans_features.jpg https://ift.tt/2CAWvxj
via IFTTT
0 comments:
Post a Comment